| Name | beta-oestradiol |
| Categories | antiepileptic, endocrinology |
| Specimen requirements | 1 ml of serum |
| Clinical utility | Men: hypogonadism, sterility diagnostics; Women: cyclic disorders, sterility diagnostics, hormonal stimulation of ovulation, in vitro fertilisation, hormone substitution after menopause, tumour marker with oestradiol-producing ovarian tumours |
| Methodology | CLIA (chemiluminescence immunoassay) |
| Reference ranges | f: Follicular phase: 21-251 pg/ml Mid-cycle: 38-649 pg/ml, Luteal phase: 21-312 pg/ml Postmenopausal: treated < 10-144 pg/ml Postmenopausal: untreated < 10-28 pg/ml m: 11-44 pg/ml |